No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
2014 · Cancer Chemotherapy and Pharmacology · 30 citations
https://doi.org/10.1007/s00280-014-2438-4